← Back to Search

Behavioral Intervention

Imitation Training for Autism (EMIT Trial)

N/A
Recruiting
Led By Meghan A Deshais, Ph.D.
Research Sponsored by Rutgers, The State University of New Jersey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 3x per week throughout participant's emit intervention, approximately 3-6 months
Awards & highlights

EMIT Trial Summary

This trial seeks to create a protocol to help autistic children learn imitation skills more quickly and effectively. Features from prior research will be included, such as teaching multiple response types, remediating slow progress, and testing for generalization.

Who is the study for?
This trial is for children aged 5 or under who have been diagnosed with autism or are on the autism spectrum. They should score no more than 40 on a Motor Vocal Imitation Assessment and no more than 36 on the Peabody Picture Vocabulary Test-5, and must be able to match identical items above chance levels.Check my eligibility
What is being tested?
The study tests a new training called EMIT designed to help autistic children imitate others better. It includes evidence-based methods for learning imitation skills across different types (motor, object, vocal) and checks if these skills can generalize beyond training.See study design
What are the potential side effects?
Since EMIT is a behavioral training intervention rather than a medication, it does not have side effects in the traditional sense. However, participants may experience frustration or fatigue during sessions.

EMIT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 3x per week throughout participant's emit intervention, approximately 3-6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 3x per week throughout participant's emit intervention, approximately 3-6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Probe performance
Secondary outcome measures
Motor Vocal Imitation Assessment

EMIT Trial Design

2Treatment groups
Experimental Treatment
Group I: Waitlist ControlExperimental Treatment1 Intervention
Delayed access to EMIT intervention
Group II: EMIT InterventionExperimental Treatment1 Intervention
Immediate access to EMIT intervention

Find a Location

Who is running the clinical trial?

Rutgers, The State University of New JerseyLead Sponsor
429 Previous Clinical Trials
64,222 Total Patients Enrolled
9 Trials studying Autism Spectrum Disorder
167 Patients Enrolled for Autism Spectrum Disorder
Meghan A Deshais, Ph.D.Principal InvestigatorRutgers University

Media Library

Emergent Multi-Class Imitation Training (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05849376 — N/A
Autism Spectrum Disorder Research Study Groups: Waitlist Control, EMIT Intervention
Autism Spectrum Disorder Clinical Trial 2023: Emergent Multi-Class Imitation Training Highlights & Side Effects. Trial Name: NCT05849376 — N/A
Emergent Multi-Class Imitation Training (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05849376 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What criteria must a participant meet to qualify for this research project?

"Candidates who wish to be considered for the trial must have a diagnosis of autism spectrum disorder and should fall between 12 months old to 6 years old. This clinical study is looking for 10 participants in total."

Answered by AI

Is this research project currently open for enrollment?

"According to clinicaltrials.gov, this experiment is presently enlisting participants; the listing was initially created on March 27th 2022 and recently updated on April 27th 2023."

Answered by AI

What is the cap on the number of participants in this experiment?

"Affirmative, clinicaltrials.gov indicates that this research effort is actively enrolling subjects. It was initially posted on March 27th 2022 and has since been updated April 27th 2023. The study aims to recruit 10 patients from 1 medical facility."

Answered by AI

Is this experiment accepting participants who are forty or older?

"The entrance requirements for this medical research specify that participants must be between one year old and six years of age. There are 231 trials available to younger patients, while those over 65 can choose from 42 different clinical studies."

Answered by AI
~1 spots leftby Aug 2024